---
figid: PMC4767488__oncotarget-06-43016-g001
figtitle: Inhibition of the Tcf/beta-catenin complex increases apoptosis and impairs
  adrenocortical tumor cell proliferation and adrenal steroidogenesis
organisms:
- Bos taurus
- Oryctolagus cuniculus
- Equus caballus
- Equus asinus
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC4767488
filename: oncotarget-06-43016-g001.jpg
figlink: /pmc/articles/PMC4767488/figure/F1/
number: F1
caption: A. When Wnt signaling is activated, the Wnt ligand binds to the Frizzled
  (Fzd) receptor and LRP5/6 (LRP) co-receptor and stimulates LRP5/6 phosphorylation
  with the help of Dishevelled (DVL). Phosphorylated LRP recruits Axin to the membrane
  and disrupts the beta-catenin degradation complex. Beta-catenin accumulates in the
  cytoplasm and enters into the nucleus, where it binds to Tcf/Lef and co-activators
  triggering Wnt target gene transcription. PNU-74654, a drug-like compound, disrupts
  the beta-catenin/Tcf complex and arrests Wnt target gene transcription. B. When
  Wnt signaling is not activated (either by Wnt ligand sequestration by sFRPs and/or
  LRP5/6 inhibition by DKK3), cytoplasmic beta-catenin is phosphorylated by the beta-catenin
  degradation complex consisting of APC, Axin, GSK3beta and CKIα. Phosphorylated beta-catenin
  is then recognized by beta-Trcp and is degraded via the ubiquitin-proteasome pathway.
papertitle: Inhibition of the Tcf/beta-catenin complex increases apoptosis and impairs
  adrenocortical tumor cell proliferation and adrenal steroidogenesis.
reftext: Letícia F. Leal, et al. Oncotarget. 2015 Dec 15;6(40):43016-43032.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9297871
figid_alias: PMC4767488__F1
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
- Oryctolagus cuniculus
- Equus asinus
- Bos taurus
- Equus caballus
redirect_from: /figures/PMC4767488__F1
ndex: d6d26dff-def5-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4767488__oncotarget-06-43016-g001.html
  '@type': Dataset
  description: A. When Wnt signaling is activated, the Wnt ligand binds to the Frizzled
    (Fzd) receptor and LRP5/6 (LRP) co-receptor and stimulates LRP5/6 phosphorylation
    with the help of Dishevelled (DVL). Phosphorylated LRP recruits Axin to the membrane
    and disrupts the beta-catenin degradation complex. Beta-catenin accumulates in
    the cytoplasm and enters into the nucleus, where it binds to Tcf/Lef and co-activators
    triggering Wnt target gene transcription. PNU-74654, a drug-like compound, disrupts
    the beta-catenin/Tcf complex and arrests Wnt target gene transcription. B. When
    Wnt signaling is not activated (either by Wnt ligand sequestration by sFRPs and/or
    LRP5/6 inhibition by DKK3), cytoplasmic beta-catenin is phosphorylated by the
    beta-catenin degradation complex consisting of APC, Axin, GSK3beta and CKIα. Phosphorylated
    beta-catenin is then recognized by beta-Trcp and is degraded via the ubiquitin-proteasome
    pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SFRP1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - DKK3
  - RPSA
  - LRP1
  - PTPRA
  - MVP
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - APC
  - PROC
  - AXIN1
  - AXIN2
  - CSNK1A1
  - GSK3B
  - CTNNB1
  - BTRC
  - HNF4A
  - Sfrp1
  - Dkk3
  - Lrp1
  - Mvp
  - Txlng
  - Dvl1
  - Apc
  - Axin1
  - Csnk1a1
  - Gsk3b
  - Ctnnb1
  - Btrc
---
